Pospos, Jerome B.

HRN: 23-65-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CEFTRIAXONE 1G (VIAL)
09/06/2023
09/13/2023
IVT
1gm
Q12
Fracture Open II Tibia And Fibula M/3rd Left
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: